SCHEMBL8476305

SCHEMBL8476305

Nc1ccc(O)cc1C(=O)NCCC(c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.56
NPSR1 Q6W5P4 2/20 0.54
CNR1 P21554 4/20 0.53
CNR2 P34972 3/20 0.53
MTNR1A P48039 1/20 0.50
MTNR1B P49286 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
HPGD P15428 2/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPT P10636 1/20 0.47
LMNA P02545 1/20 0.46
TPSAB1 Q15661 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17774887 0.77 NSD2 (0.58) KMT2AHPGDCYP2C9CYP2C19ALDH1A1
SCHEMBL4639773 0.77 EPHX2 (0.66) EPHX2NPSR1CNR1CNR2MTNR1A
SCHEMBL5947652 0.77 EPHX2 (0.81) EPHX2NPSR1CNR1CNR2MTNR1A
SCHEMBL8473138 0.74 NAAA (0.56) EPHX2NPSR1CNR1CNR2ALDH1A1
SCHEMBL6887760 0.73 NAAA (0.48) HPGDALDH1A1LMNA
SCHEMBL3138003 0.73 MEN1 (0.48) MEN1KMT2ALMNA
SCHEMBL5947857 0.73 EPHX2 (0.63) EPHX2NPSR1CNR1CNR2MTNR1A
SCHEMBL5948102 0.73 EPHX2 (1.00) EPHX2NPSR1CNR1CNR2MTNR1A
SCHEMBL3132663 0.72 NSD2 (0.49) MEN1KMT2AHPGDALDH1A1LMNA
SCHEMBL8477486 0.72 HTR4 (0.43) CNR1MEN1KMT2AALDH1A1TPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5872115-A COMPOUNDS FOR TREATMENT OF HYPERCHOLESTEROLEMIA, ISCHEMIC HEART DISEASE, CEREBROVASCULAR DISEASE OR ATHEROSCLEROSIS GRELAN PHARMACEUTICAL CO. LTD. (JP) 1999-02-16 US disclosed
EP-0742208-A1 2-Ureido-benzamide derivatives GRELAN PHARMACEUTICAL CO., LTD. (JP) 1996-11-13 EP disclosed